Add BrightSurf on Google Email

JCI online early table of contents: Jan. 9, 2012

A team of researchers identified genetic mutations in OATP1B1 and OATP1B3 as the cause of Rotor syndrome, a rare genetic disorder characterized by jaundice. Complete deficiency of these proteins causes human Rotor syndrome by interrupting conjugated bilirubin reuptake into the liver.

SourceJCI Journals·JournalJournal of Clinical Investigation·DateJan 9, 2012

Genetic and mechanistic basis for rotor syndrome uncovered

Researchers identified genetic mutations in OATP1B1 and OATP1B3 proteins as the underlying cause of Rotor syndrome, a condition characterized by conjugated bilirubin buildup. Complete deficiency of these proteins can cause hypersensitivity to certain drugs and interrupt conjugated bilirubin reuptake into the liver.

SourceJCI Journals·JournalJournal of Clinical Investigation·DateJan 9, 2012

Key genetic error found in family of blood cancers

Researchers have identified a critical genetic mutation in patients with myelodysplastic syndromes, which can progress to leukemia. The mutation is found in nearly 9% of patients, increasing the risk of developing acute leukemia by almost three times. The study raises hopes for improved diagnosis and treatment of this blood cancer.

SourceWashU Medicine·JournalNature Genetics·DateDec 15, 2011

Exercise provides clue to deadly ataxia

Researchers discovered that brief periods of exercise in early life increased survival rates in mice with spinocerebellar ataxia 1 (SCA1), a devastating inherited disorder. Exercise reduced levels of capicua, a protein partner of ataxin1, which improved symptoms and extended lifespan.

SourceBaylor College of Medicine·JournalScience·DateNov 3, 2011

Unraveling Batten disease

Researchers have discovered that a mutation in the CLN3 gene disrupts protein trafficking, leading to lysosome overflow and neuronal death in Batten disease. The findings may form the basis for a new therapy by targeting the kinase function of CLN3.

SourceWeizmann Institute of Science·JournalJournal of Cell Biology·DateNov 2, 2011

The search for predictors of risk for PTSD

A study found a link between a serotonin transporter gene variant and PTSD risk, suggesting the gene may predict symptom development after trauma. The researchers also discovered that this gene is associated with depression following life stress, highlighting its potential role in mental health.

Molecular mechanisms offer hope for new pain treatments

Geneticists at the University of Montreal have discovered a key gene involved in pain perception, which could lead to new pain relief drugs. The study identified a genetic mutation that causes hereditary sensory and autonomic neuropathy type II, a severe disorder characterized by degeneration of sensory neurons.

SourceUniversity of Montreal·JournalAmerican Journal of Human Genetics·DateAug 4, 2011

Yale researchers uncover source of mystery pain

An international team of scientists found that mutations in the SCN9A gene cause nerve cells to become hyperactive, leading to degeneration of nerve fibers and severe pain in patients with peripheral neuropathy. The discovery could lead to specific therapies for victims of this debilitating disorder.

SourceYale University·JournalAnnals of Neurology·DateJun 22, 2011

Innovative screening method identifies possible new treatment for fatal childhood disease

Researchers at Columbia University Irving Medical Center have developed an innovative yeast-based screening method to identify a possible new treatment for the fatal childhood disease NP-C. The approach, known as 'exacerbate-reverse', has shown promising results in repairing genetic pathways that exacerbate lethality in yeast models.

SourceColumbia University Irving Medical Center·JournalJournal of Biological Chemistry·DateApr 18, 2011

Intellectual disability is frequently caused by non-hereditary genetic problems

Researchers identified mutations in genes associated with brain activity that frequently cause intellectual disability. These de novo mutations disrupt nerve cell communication, affecting at least two-thirds of cases. The study provides new insights into the genetic origins of intellectual disability and may lead to improved diagnostics.

SourceUniversity of Montreal·JournalAmerican Journal of Human Genetics·DateApr 18, 2011

Micro-RNA's contribute to risk for panic disorder

Researchers found that four microRNAs (miR-22, miR-138-2, miR-148a, and miR-488) are associated with panic disorder, regulating genes related to anxiety pathways in the brain. The study suggests a coordinated involvement of multiple risk genes, implying the existence of molecular 'switches' that control gene function.

SourceElsevier·JournalBiological Psychiatry·DateMar 24, 2011

Scientists identify susceptibility factor for bipolar disorder

A new study reveals a previously unrecognized susceptibility factor for bipolar disorder, with genetic variation in the neurocan (NCAN) gene associated with an increased risk. The findings suggest that NCAN variants may disturb neuronal processes in patients with bipolar disorder, leading to cognitive deficits.

SourceCell Press·JournalAmerican Journal of Human Genetics·DateMar 3, 2011

NIH researchers identify genetic cause of new vascular disease

Researchers at the National Institutes of Health's Undiagnosed Diseases Program have identified a novel disorder characterized by progressive and painful arterial calcification affecting the lower extremities. The condition, associated with mutations in the NT5E gene, has been observed in nine individuals from three unrelated families.

SourceNIH/National Human Genome Research Institute·JournalNew England Journal of Medicine·DateFeb 2, 2011

New hope in fight against Huntington's disease

Researchers from the University of Leicester and international partners have identified potential new therapeutic targets for Huntington's disease using cutting-edge genetic techniques. The study found that flavonoids can prevent cell death in yeast, suggesting a possible new treatment approach.

SourceUniversity of Leicester·JournalJournal of Biological Chemistry·DateJan 10, 2011

Genetic alteration linked with disorders of sex determination

A study published in the American Journal of Human Genetics reveals a genetic alteration, MAP3K1, responsible for disorders of sex determination (DSD). The discovery provides insight into the cause of DSDs and contributes to better management, including the importance of removing gonads early to prevent cancer.

SourceCell Press·JournalAmerican Journal of Human Genetics·DateDec 2, 2010